Ms Lesley S.K. LAU
|
Research Coordinator |
|
 |
Professorial Block, Queen Mary Hospital |
 |
(852)-2855-0947 |
Publications
2024
- Lai THT, Lau LSK, Ngu SF, Chu MYM, Chan KKL, Ng EHY, Ngan HYS, Li RHW, Tse KY. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study. Cancer Med. 2024 Apr;13(7):e7134.
2023
- Kwok ST, Chan KKL, Tse KY, et al. Outcome after loop electrosurgical excision procedure for cervical high-grade squamous intraepithelial lesion. Taiwan J Obstet Gynecol. 2023;62(1):45-49. doi:10.1016/j.tjog.2022.10.004
- Luk, H.M.; Ngu, S.F.; Lau, L.S.K.; Tse, K.Y.; Chu, M.M.Y.; Kwok, S.T.; Ngan, H.Y.S.; Chan, K.K.L. Patient-Initiated Follow-Up in Ovarian Cancer. Curr. Oncol. 2023, 30, 3627-3636. https://doi.org/10.3390/curroncol30040276
2022
- Ngu S.F., Lau S.K., Li J., Wong C.Y.G., Cheung A.N.Y., Ngan H.Y.S. and Chan K.K.L., Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic., Int J Environ Res Public Health.. 2022, 19(5), 2610.
2020
- Chan K.K.L., Liu S., Wei N., Ngu S.F., Chu M.Y.M., Tse K.Y., Lau S.K., Cheung A.N.Y. and Ngan H.Y.S., Primary HPV testing with cytology versus cytology alone in cervical screening—A prospective randomized controlled trial with two rounds of screening in a Chinese population , International Journal of Cancer. 2020. http://dx.doi.org/10.1002/ijc.32861
2018
Liu S., Chan K.K.L., Chu K.H., Wei N., Lau S.K., Ngu S.F., Chu M.Y.M., Tse K.Y., Ip P.C.P., Ng E.K.O., Cheung A.N.Y. and Ngan H.Y.S., Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer, 2018. http://dx.doi.org/10.1002/1878-0261.12383(Publication No. : 294143)
2016
KY Tse, SK Lau, MW Lui, PPC Ip, ANY Cheung, HYS Ngan. Patient compliance with cervical smear surveillance in a shared-care setting. Int J Gyn Obs 2016; 135: 177 - 81
2011
Chan KK, Yao TJ, Jones B, Zhao JF, Ma FK, Leung CY, Lau SK, Yip MW, Ngan HY. The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring. Ann Oncol. 2011 Oct;22(10):2241-9. [PubMed]
